Aktionärsstruktur

Inhaber in %
Freefloat 1,00
Fidelity Management & Research Co. 0,11
T. Rowe Price Associates, Inc. (Investment Management) 0,10
The Vanguard Group, Inc. 0,07
Vanguard Group, Inc. (Subfiler) 0,07
T. Rowe Price Associates, Inc. (Investment Management) 0,06
SSgA Funds Management, Inc. 0,05
State Street Corp. 0,05
Baker Bros. Advisors LP 0,04
Baker Bros. Advisors LP 0,04
ClearBridge Investments LLC 0,03
BlackRock Fund Advisors 0,03
Vanguard Total Stock Market Index Fund 0,03
Government Pension Fund - Global (the) 0,02
Norges Bank (13F) 0,02

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2014 2015 2016 2017 2018
Personal am Ende des Jahres 0 0 0 0 0
Umsatz pro Mitarbeiter in Mio. EUR 0,00 0,00 0,00 0,00 0,00

Bilanz (in Mio. EUR) - Aktiva

2014 2015 2016 2017 2018
Summe Umlaufvermögen 2.796.029 2.425.349 2.578 29.539 3.385
Summe Anlagevermögen 3.359.518 11.714.866 11.749 117.812 123.718
Summe Aktiva 4.201.962 1.313.323 13.253 135.833 139.319

Bilanz (in Mio. EUR) - Passiva

2014 2015 2016 2017 2018
Gesamtverschuldung/ -verbindlichkeiten 575 345.625 3.055 28.881 32.065
Summe Fremdkapital 899.944 4.874.614 4.559 46.902 47.666
Summe Eigenkapital 3.302.018 8.258.616 8.694 88.931 91.653
Summe Passiva 4.201.962 1.313.323 13.253 135.833 139.319

Adresse

121 Seaport Boulevard, 02210 Boston
Telefon 1.475.230.2596
Fax 1.203.271.8198
Internet http://www.alexion.com

Management

Andreas Rummelt
Independent Director
Anne-Marie Law
Chief Human Experience Officer & Executive VP
Aradhana Sarin
Chief Financial Officer & Executive Vice President
Brian M. Goff
Chief Commercial, Global Operations Officer & EVP
Christopher J. Coughlin
Independent Director
Daniel A. Bazarko
Chief Accounting Officer & Senior Vice President
David Richard Brennan
Chairman
Deborah L. Dunsire
Independent Director
Douglas J. Barry
Vice President-Corporate Law
Ellen V. Chiniara
Secretary, General Counsel & Executive VP
Felix James Baker
Independent Director
Francois Nader
Independent Director
Indrani M. Franchini
Chief Compliance Officer & Executive VP
John J. Orloff
Executive VP, Head-Research & Development
John T. Mollen
Independent Director
John V. W. Reynders
Vice President-R&D Bioinformatics
Judith A. Reinsdorf
Independent Director
Ludwig N. Hantson
Chief Executive Officer & Director
Paul A. Friedman
Independent Director
Rana Strellis
SVP-Global Culture & Social Responsibility
Susan Altschuller
Vice President-Investor Relations
Tanisha V. Cariño
Chief Corporate Affairs Officer & EVP